Ctic stock earnings
WebApr 9, 2024 · 6 brokers have issued 12 month price targets for CTI BioPharma's shares. Their CTIC share price forecasts range from $9.00 … WebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI …
Ctic stock earnings
Did you know?
WebApr 7, 2024 · CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. … WebCTIC Stock Price - CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the ...
Web2 days ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … WebApr 10, 2024 · SEATTLE, April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of …
WebApr 10, 2024 · CTIC Stock Overview. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted … WebCTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates. CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024 ...
WebSee CTI BioPharma Corp. (CTIC) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
WebCTI BioPharma (CTIC) Stock Price & Analysis. Follow. 855 Followers. Portfolio. CTIC Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 - $0. ... im not lisa chordsWebApr 10, 2024 · The equity awards were approved on April 10, 2024, in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an aggregate of 36,000 shares of CTI BioPharma common stock. The options will be issued upon each employee's grant date (the "Grant Date"), and all stock options included … im not listening t shirtWeb1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies … list of words with orWebMar 14, 2024 · Shares of CTIC stock opened at $4.47 on Tuesday. The stock has a market capitalization of $589.32 million, a price-to-earnings ratio of -5.26 and a beta of 0.91. CTI BioPharma has a twelve month ... im not leaving until i eat this by john edgeWebApr 8, 2024 · CTI BioPharma last announced its earnings data on March 6th, 2024. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, … im not living just existingWebMar 17, 2024 · CTI BioPharma Corp. analyst estimates, including CTIC earnings per share estimates and analyst recommendations. list of words that start with unWebStock Quote. Change Volume 52 Week High 52 Week Low Apr 13, 2024 1:41 PM EDT. Data Provided by Refinitiv. ... Wash. , April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today … im not looking for absolution